Assessing Psoriasis Treatment Outcomes

To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.

Inclusion Criteria: * Patients ≥18 years of age * Patients with a current diagnosis of psoriasis suitable for treatment with topical Betamethasone (BD) * Patients who live in the United States * Patients with a sufficient command of the English language * Patients with a mobile device able to at least operate at 25 frames per second (FPS). Exclusion Criteria: * Patients less than the age of 18 * Patients with severe or unstable comorbid conditions * Patient who are pregnant or breastfeeding * Patients with any other skin conditions that prohibit or confound the ability of the investigator to interpret skin findings * Patients that are taking concomitant topical or systemic therapy for the treatment of psoriasis and/or phototherapy * Patients without mobile devices able to at least operate at 25 frames per second (FPS). * Patients without a current diagnosis of psoriasis suitable for treatment with topical BD